7,531
Views
372
CrossRef citations to date
0
Altmetric
Technical Reports

Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis

, , , &
Article: 19671 | Received 05 Sep 2012, Accepted 10 Jan 2013, Published online: 15 Feb 2013

References

  • Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, et al.. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011; 7: 780–8. 10.3402/jev.v2i0.19671.
  • Saveyn H, De BB, Thas O, Hole P, Smith J, Van der Meeren P. Accurate particle size distribution determination by nanoparticle tracking analysis based on 2-D Brownian dynamics simulation. J Colloid Interface Sci. 2010; 352: 593–600. 10.3402/jev.v2i0.19671.
  • Van der Meeren P, Kasinos M, Saveyn H. Relevance of two-dimensional Brownian motion dynamics in applying nanoparticle tracking analysis. Methods Mol Biol. 2012; 906: 525–34.
  • Carr R, Hole P, Malloy A, Nelson P, Smith J. Applications of nanoparticle tracking analysis (NTA) in nanoparticle research – a mini-review. Eur J Parent Pharmaceut Sci. 2009; 14: 45–50.
  • Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010; 27: 796–810. 10.3402/jev.v2i0.19671.
  • Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010; 77: 502–14.
  • Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost. 2011; 105: 396–408. 10.3402/jev.v2i0.19671.
  • Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al.. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res. 2011; 127: 370–7. 10.3402/jev.v2i0.19671.
  • Trummer A, De RC, Tiede A, Ganser A, Eisert R. Recovery and composition of microparticles after snap-freezing depends on thawing temperature. Blood Coagul Fibrinolysis. 2009; 20: 52–6. 10.3402/jev.v2i0.19671.
  • Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, et al.. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost. 2012; 10: 437–46. 10.3402/jev.v2i0.19671.
  • Chandler WL, Yeung W, Tait JF. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost. 2011; 9: 1216–24. 10.3402/jev.v2i0.19671.
  • van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012; 10: 919–30. 10.3402/jev.v2i0.19671.
  • El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, et al.. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc. 2012; 7: 2112–26. 10.3402/jev.v2i0.19671.
  • Sheldon H, Heikamp E, Turley H, Dragovic R, Thomas P, Oon CE, et al.. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood. 2010; 116: 2385–94. 10.3402/jev.v2i0.19671.
  • Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem. 2012; 428: 44–53. 10.3402/jev.v2i0.19671.
  • Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, et al.. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011; 87: 146–50. 10.3402/jev.v2i0.19671.
  • Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost. 2011; 9: 2251–61. 10.3402/jev.v2i0.19671.
  • Gyorgy B, Szabo TG, Turiak L, Wright M, Herczeg P, Ledeczi Z, et al.. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS One. 2012; 7: e49726. 10.3402/jev.v2i0.19671.